Capula Management’s Medtronic MDT Stock Holding History

Capula Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$606K	Buy	6,991 +4,405	+170%	+$422K	﹤0.01%	469
2025 Q4	$248K	Sell	2,586 -275	-10%	-$26.7K	﹤0.01%	532
2025 Q3	$272K	Buy	2,861 +1,728	+153%	+$159K	﹤0.01%	542
2025 Q2	$98.8K	Sell	1,133 -169	-13%	-$14.3K	﹤0.01%	505
2025 Q1	$117K	Buy	+1,302	New	+$117K	﹤0.01%	605
2024 Q4	–	Sell	-4,312	Closed	-$388K	–	512
2024 Q3	$388K	Buy	+4,312	New	+$363K	﹤0.01%	274
2023 Q2	–	Sell	-5,278	Closed	-$454K	–	647
2023 Q1	$426K	Sell	5,278 -58,150	-92%	-$4.74M	0.01%	491
2022 Q4	$4.93M	Sell	63,428 -24,957	-28%	-$2.02M	0.07%	260
2022 Q3	$7.14M	Buy	+88,385	New	+$7.94M	0.1%	210
2021 Q4	–	Sell	-22,462	Closed	-$2.81M	–	550
2021 Q3	$2.81M	Buy	22,462 +1,058	+5%	+$137K	0.03%	343
2021 Q2	$2.66M	Buy	21,404 +18,970	+779%	+$2.38M	0.04%	259
2021 Q1	$288K	Buy	+2,434	New	+$285K	0.01%	426
2020 Q3	–	Sell	-24,905	Closed	-$2.28M	–	256
2020 Q2	$2.28M	Buy	24,905 +21,430	+617%	+$2.05M	0.08%	197
2020 Q1	$313K	Buy	+3,475	New	+$370K	0.01%	344

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capula Management's MDT Position: Q1 2026 in Review

Capula Management increased its Medtronic (MDT) stake by 170% in Q1 2026, buying an estimated $422K and bringing the position to 6,991 shares worth $606K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

Capula Management first reported a position in MDT in Q1 2020 and has held it in 14 quarters since. The position peaked at $7.14M in Q3 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Capula Management held 6,991 shares of Medtronic worth $606K as of Q1 2026.
Capula Management bought 4,405 Medtronic shares in Q1 2026, an estimated $422K.
Medtronic made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #469 holding.
Capula Management first reported a position in Medtronic in Q1 2020 and has held it in 14 quarters since.
Capula Management's Medtronic position peaked at $7.14M in Q3 2022.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.